国药PK华润医药:中药掉队,血制品称王

E药经理人
26 Feb

“国药系”和“华润系”,堪称中国医药产业中的两列巨型舰队,都力图在保稳健的同时保发展,但双方的经营侧重点存在着显著不同。撰文|石若萧谈论中国医药产业,“国药系”和“华润系”无疑是两家绕不开的巨头:都体量庞大,都擅长并购,都布局广泛,都在保稳健的同时保发展。国药系旗下共有10家药械上市公司:流通类上市公司国药控股、国药一致、国药股份3家;中药上市公司中国中药、太极集团;血液制品天坛生物、卫光生物;...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10